Brendon Stiles

@BrendonStilesMD

Thoracic surgeon. Cancer researcher. Patient advocate. Expecting excellence.

New York, NY
weillcornell.org/bstiles
Vrijeme pridruživanja: prosinac 2013.
1.058 fotografija ili videozapisa Fotografije i videozapisi

Tweetovi

Blokirali ste korisnika/cu @BrendonStilesMD

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @BrendonStilesMD

  1. Prikvačeni tweet
    3. stu 2016.

    Here is a closing thought. From my Dad's grave stone. Live by this creed.

    17 replies 311 proslijeđenih tweetova 824 korisnika označavaju da im se sviđa
    Poništi
  2. proslijedio/la je Tweet
    4. velj

    This , join as we strive to create a cancer-free world for all of our patients and their loved ones. CC: &

    28 proslijeđenih tweetova 55 korisnika označava da im se sviđa
    Poništi
  3. 4. velj

    Interesting talk by Lew Cantley, Director, on PI3K and . Touched on ketogenic diet trials for cancer led by here . Insulin control is key for response to PI3K inhibitors.

    1 proslijeđeni tweet 14 korisnika označava da im se sviđa
    Poništi
  4. proslijedio/la je Tweet
    2. velj

    Devastated to report that our community lost an amazing advocate and friend. Don Stranathan died suddenly early this morning. He helped countless patients over his many years of survivorship. Words cannot adequately describe how sorely he’ll be missed.

    9 replies 22 proslijeđena tweeta 66 korisnika označava da im se sviđa
    Poništi
  5. proslijedio/la je Tweet
    1. velj

    One day left to donate. Are you a member of the ? If every member donated $10, these girls would reach their goal. If you believe then help Team Hope raise money for . LungCancer Survivor Challenge. One day left!

    1 proslijeđeni tweet 5 korisnika označava da im se sviđa
    Poništi
  6. proslijedio/la je Tweet
    1. velj
    Odgovor korisnicima i sljedećem broju korisnika:

    While the pundits are debating screening many of us are doing it responsibly, continuously improving the process and saving lives

    1 reply 7 proslijeđenih tweetova 19 korisnika označava da im se sviđa
    Poništi
  7. 31. sij

    Odgovor korisnicima @hranganath @drdavidpalma i sljedećem broju korisnika: 2
    Oh, there’s a big difference: not all ways to die suck equally on the way there. This is not a binary set of outcomes.
    4 korisnika označavaju da im se sviđa
    Poništi
  8. proslijedio/la je Tweet
    31. sij

    Exciting to see NELSON screening trial results published in . In the attached graphic, our CSO, , provides his perspective on the trial's implications. Watch NELSON investigator, Harry J. de Koning, discuss the trial at :

    , , i još njih 7
    1 reply 26 proslijeđenih tweetova 41 korisnik označava da mu se sviđa
    Poništi
  9. 30. sij

    Always a complex topic. Lots still to learn. But careful, accurate classification of nodal stations is key for comparisons. I believe neoadjuvant ICB will eventually have a role in selected patients and that it will raise survival bar. But we need to prove it.

    . discusses surgery for N2 disease. Most surgery in UK is primary and not post induction chemo-RT. Important to subclassify N2 for routine datasets. How to inter grants IO? Need data on LungART and IO trials
    2 proslijeđena tweeta 14 korisnika označava da im se sviđa
    Poništi
  10. 30. sij

    Yankelevitz: Who among us has ever diagnosed a case of overdiagnosis?!?! How? -PALS

    1 reply 1 proslijeđeni tweet 7 korisnika označava da im se sviđa
    Poništi
  11. 30. sij

    The esteemed Dr. Yankelevitz explaining why lung cancer overdiagnosis has been overdiagnosed and why so many are incorrect in their thinking about the concept. -PALS

    5 korisnika označava da im se sviđa
    Poništi
  12. 30. sij

    Tremendous talk from ⁦⁩ about the Manchester Lung Health Check pilot program. Incredible effort reaching some of the most at risk patients. Clearly demonstrates the potential and value of mobile screening units. Great presentation.

    1 reply 2 proslijeđena tweeta 19 korisnika označava da im se sviđa
    Poništi
  13. 30. sij

    Current estimated rates of lung cancer screening of our at risk and eligible veterans are inexcusable. We have to do better. ⁦⁩ ⁦⁩

    14 proslijeđenih tweetova 37 korisnika označava da im se sviđa
    Poništi
  14. 30. sij

    ⁦⁩ opens the VA-PALS summit with a reminder about why we are here - to help our veterans and decrease their mortality from lung cancer. The ⁦⁩ is a “no stigma” zone.

    2 proslijeđena tweeta 21 korisnik označava da mu se sviđa
    Poništi
  15. proslijedio/la je Tweet
    29. sij

    Let’s increase the sample size by retweeting this. We need more data to better understand the scale of misunderstanding of the NLST.

    I'm really curious. What % interm or major complications do people think actually occurred in people who underwent LDCT scans in the NLST trial but never had cancer?
    1 reply 5 proslijeđenih tweetova 9 korisnika označava da im se sviđa
    Poništi
  16. 29. sij

    Looking forward to attending this important summit. We must do better screening at-risk veterans for lung cancer.

    My thanks to and for arranging this second annual summit. With 5,500 Veterans dying yearly from , increasing access to early detection screening programs is critical.
    6 proslijeđenih tweetova 16 korisnika označava da im se sviđa
    Poništi
  17. 28. sij

    Please take a look at the question below!

    I'm really curious. What % interm or major complications do people think actually occurred in people who underwent LDCT scans in the NLST trial but never had cancer?
    1 reply 2 proslijeđena tweeta 6 korisnika označava da im se sviđa
    Poništi
  18. 23. sij

    Great work on detecting and careful management of lung nodules.

    Congratulations to Dr. of on her study describing the experience of the first 1000+ patients seen in the integrated, multidiscplinary pulmonary nodule program at MGH! Read more:
    Prikaži ovu nit
    1 proslijeđeni tweet 8 korisnika označava da im se sviđa
    Poništi
  19. proslijedio/la je Tweet
    23. sij

    Not much of a slice, is it?

    26 proslijeđenih tweetova 34 korisnika označavaju da im se sviđa
    Poništi
  20. proslijedio/la je Tweet
    23. sij

    Summary of Top 5 advances in for over past decade, by & myself, is now available on We welcome your thoughts!

    1 reply 25 proslijeđenih tweetova 45 korisnika označava da im se sviđa
    Poništi
  21. proslijedio/la je Tweet
    23. sij

    The latest Nature Collection series on metastasis features two reviews on lung cancer microenvironment and EMT by our own Neuberger Berman Lung Cancer Center investigators Drs. Mittal and Ga.

    3 proslijeđena tweeta 9 korisnika označava da im se sviđa
    Poništi

@BrendonStilesMD još nije objavio nijedan Tweet.

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·